Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference

Rhea-AI Summary

Relmada Therapeutics (Nasdaq: RLMD), a clinical-stage biotechnology company focused on oncology and central nervous system disorders, announced that senior management will participate in one-on-one meetings at the Wells Fargo 21st Annual Healthcare Conference in Boston, MA, from September 8–10, 2026.

Investors can request 1×1 meetings through their Wells Fargo representative.

Market Context

RLMD’s recent record included a -8.01% reaction to its Q2 earnings update and a +4.33% reaction to i...

Analysis

RLMD’s recent record included a -8.01% reaction to its Q2 earnings update and a +4.33% reaction to index inclusion, showing event-specific variation. This notice adds no quantified result; the active S-3ASR remains a financing risk context.

Key Figures

Announcement date: September 1, 2026 Conference edition: 21st annual Conference dates: September 8–10, 2026 +1 more

4 metrics

Announcement date September 1, 2026 Conference participation announcement

Conference edition 21st annual Wells Fargo Healthcare Conference

Conference dates September 8–10, 2026 Wells Fargo Healthcare Conference

Meeting format 1×1 meetings Management meetings at the conference

Historical Context

5 past events · Latest: Aug 06 (Negative)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Aug 06	Q2 earnings	Negative	-8.0%	Second-quarter results included a net loss and increased research and development expense.
Jul 28	Executive appointment	Positive	+0.6%	Bipin Dalmia joined as chief business officer to lead strategy and business development.
Jul 16	Earnings date notice	Neutral	-12.1%	The company scheduled its second-quarter results conference call for August 6, 2026.
Jun 29	Index inclusion	Positive	+4.3%	Relmada joined the Russell 2000 and Russell 3000 indexes after the June 26 market close.
Jun 11	Advisor appointment	Positive	+2.2%	Michael Quirk became senior advisor for the sepranolone program.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

RLMD’s recent reactions generally aligned with the apparent direction of company developments, while a routine earnings-date notice diverged.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CORAL GABLES, Fla., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, today announced that senior management will participate in one-on-one meetings at the Wells Fargo 21st Annual Healthcare Conference being held in Boston, MA, from September 8 - 10, 2026.

Wells Fargo 21st Annual Healthcare Conference Details
Format: One-on-one Meetings
Date: September 8 - 10, 2026

If you are interested in arranging a 1×1 meeting with management at the conference, please contact your Wells Fargo representative.

About Relmada Therapeutics, Inc.

Relmada Therapeutics is a clinical-stage biotechnology company focused on developing transformative therapies for oncology and central nervous system conditions. Its lead candidates, NDV-01 and sepranolone, are advancing through clinical development with the potential to address significant unmet needs.

For more information, visit www.relmada.com

Investor Contact:
Brian Ritchie
LifeSci Advisors
britchie@lifesciadvisors.com

Media Inquiries:
Corporate Communications
media@relmada.com

FAQ

When will Relmada Therapeutics (RLMD) attend the Wells Fargo 21st Annual Healthcare Conference in 2026?

Relmada Therapeutics will participate in the Wells Fargo 21st Annual Healthcare Conference from September 8–10, 2026. According to Relmada, senior management will be available in Boston, MA, for scheduled one-on-one meetings with investors during the conference dates.

What is Relmada Therapeutics (RLMD) doing at the Wells Fargo 21st Annual Healthcare Conference?

Relmada Therapeutics plans to hold one-on-one meetings with investors at the Wells Fargo 21st Annual Healthcare Conference. According to Relmada, senior management will meet individually with interested parties to discuss the company at the Boston event from September 8–10, 2026.

How can investors schedule a one-on-one meeting with Relmada Therapeutics (RLMD) at the 2026 Wells Fargo Healthcare Conference?

Investors can arrange a one-on-one meeting with Relmada Therapeutics by contacting their Wells Fargo representative. According to Relmada, meeting requests for the September 8–10, 2026 conference in Boston are coordinated directly through Wells Fargo’s conference channels.

Where will Relmada Therapeutics (RLMD) hold meetings during the Wells Fargo 21st Annual Healthcare Conference?

Relmada Therapeutics will hold investor one-on-one meetings in Boston, Massachusetts, during the Wells Fargo 21st Annual Healthcare Conference. According to Relmada, these meetings are scheduled over September 8–10, 2026, and are organized through investors’ Wells Fargo representatives.